• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧对肿瘤微环境中免疫反应的调节

Immune response regulation in the tumor microenvironment by hypoxia.

作者信息

Labiano Sara, Palazon Asis, Melero Ignacio

机构信息

Oncology and Immunology Department, CIMA, Pamplona, Spain.

Physiological Laboratory, Department of PDN, University of Cambridge, Cambridge, UK.

出版信息

Semin Oncol. 2015 Jun;42(3):378-86. doi: 10.1053/j.seminoncol.2015.02.009. Epub 2015 Feb 13.

DOI:10.1053/j.seminoncol.2015.02.009
PMID:25965356
Abstract

Lymphocytes and myeloid cells sense hypoxia by the hypoxia-inducible factor (HIF) transcriptional system and via other molecular mechanisms. Low O2 availability is a hallmark of most solid tumors in which infiltrating leukocytes experience severe hypoxia once away from nurturing blood vessels. HIF controls migration, differentiation, and effector functions on immune cells. Importantly, in the tumor microenvironment the hypoxia response modulates the expression levels for important molecular targets in immunotherapy such as CD137, OX-40, FOXP3, and PD-L1. Modulation by hypoxia of tumor-associated macrophages, myeloid-derived suppressor cells, and dendritic cells ought to play an important underexplored role in modulating tumor immunity. Overall, low O2 seems to invigorate some anti-tumor effector T-cell functions while conflictingly favoring T-regulatory cells (Tregs) in terms of their differentiation, suppressive functions, and recruitment. Hypoxia also has been shown to uphold myeloid cell-mediated tumor-promoting inflammation and the immunosuppressive functions of tumor-associated macrophages. Detailed research of this intricate and poorly understood balance is warranted to improve the outcome of cancer immunotherapy.

摘要

淋巴细胞和髓样细胞通过缺氧诱导因子(HIF)转录系统及其他分子机制感知缺氧。低氧可用性是大多数实体瘤的一个标志,在实体瘤中,浸润的白细胞一旦远离滋养血管就会经历严重缺氧。HIF控制免疫细胞的迁移、分化和效应功能。重要的是,在肿瘤微环境中,缺氧反应调节免疫治疗中重要分子靶点的表达水平,如CD137、OX - 40、FOXP3和PD - L1。缺氧对肿瘤相关巨噬细胞、髓源性抑制细胞和树突状细胞的调节,在调节肿瘤免疫方面应该起着重要但尚未充分探索的作用。总体而言,低氧似乎能增强一些抗肿瘤效应T细胞的功能,而在T调节细胞(Tregs)的分化、抑制功能和募集方面却又矛盾地对其有利。缺氧还被证明能维持髓样细胞介导的肿瘤促进炎症以及肿瘤相关巨噬细胞的免疫抑制功能。有必要对这种复杂且了解不足的平衡进行详细研究,以改善癌症免疫治疗的效果。

相似文献

1
Immune response regulation in the tumor microenvironment by hypoxia.缺氧对肿瘤微环境中免疫反应的调节
Semin Oncol. 2015 Jun;42(3):378-86. doi: 10.1053/j.seminoncol.2015.02.009. Epub 2015 Feb 13.
2
The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.肿瘤浸润性 T 淋巴细胞中的 HIF-1α 低氧反应诱导功能性 CD137(4-1BB)用于免疫治疗。
Cancer Discov. 2012 Jul;2(7):608-23. doi: 10.1158/2159-8290.CD-11-0314. Epub 2012 Jun 19.
3
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer.分子通路:免疫细胞中应对或促进癌症的缺氧反应。
Clin Cancer Res. 2012 Mar 1;18(5):1207-13. doi: 10.1158/1078-0432.CCR-11-1591. Epub 2011 Dec 28.
4
Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.缺氧诱导因子在肿瘤微环境免疫反应调控中的作用
Immunology. 2014 Dec;143(4):512-9. doi: 10.1111/imm.12380.
5
Effect of tumor cells and tumor microenvironment on NK-cell function.肿瘤细胞和肿瘤微环境对 NK 细胞功能的影响。
Eur J Immunol. 2014 Jun;44(6):1582-92. doi: 10.1002/eji.201344272.
6
The impact of hypoxia on immune state in cancer.缺氧对癌症免疫状态的影响。
Life Sci. 2021 Dec 1;286:120057. doi: 10.1016/j.lfs.2021.120057. Epub 2021 Oct 16.
7
Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?巨噬细胞、髓源性抑制细胞和中性粒细胞是衰老宿主健康组织和癌组织中局部抑制的介质吗?
Exp Gerontol. 2014 Jun;54:53-7. doi: 10.1016/j.exger.2013.11.009. Epub 2013 Nov 28.
8
The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes.乳腺癌中异质性免疫微环境受缺氧相关基因影响。
Immunobiology. 2014 Feb;219(2):158-65. doi: 10.1016/j.imbio.2013.09.003. Epub 2013 Sep 8.
9
Natural killer cells and solid tumors.自然杀伤细胞与实体瘤。
J Innate Immun. 2011;3(4):355-64. doi: 10.1159/000325465. Epub 2011 Apr 18.
10
HIF transcription factors, inflammation, and immunity.缺氧诱导因子转录因子、炎症与免疫。
Immunity. 2014 Oct 16;41(4):518-28. doi: 10.1016/j.immuni.2014.09.008.

引用本文的文献

1
Single-cell spatial proteomics of non-relapse small cell lung cancer identifies tumor microenvironment determinants of survival.非复发性小细胞肺癌的单细胞空间蛋白质组学确定了生存的肿瘤微环境决定因素。
Cell Biol Toxicol. 2025 Jun 17;41(1):106. doi: 10.1007/s10565-025-10056-0.
2
Brachytherapy: Perspectives for combined treatments with immunotherapy.近距离放射治疗:与免疫疗法联合治疗的前景。
Clin Transl Radiat Oncol. 2025 Jan 19;52:100924. doi: 10.1016/j.ctro.2025.100924. eCollection 2025 May.
3
Cross-priming in cancer immunology and immunotherapy.
癌症免疫学与免疫治疗中的交叉呈递
Nat Rev Cancer. 2025 Apr;25(4):249-273. doi: 10.1038/s41568-024-00785-5. Epub 2025 Jan 29.
4
GP73 reinforces cytotoxic T-cell function by regulating HIF-1α and increasing antitumor efficacy.GP73通过调节缺氧诱导因子-1α(HIF-1α)并增强抗肿瘤疗效来强化细胞毒性T细胞功能。
J Immunother Cancer. 2025 Jan 6;13(1):e009265. doi: 10.1136/jitc-2024-009265.
5
Cancer cell-specific PD-L1 expression is a predictor of poor outcome in patients with locally advanced oral cavity squamous cell carcinoma.癌细胞特异性程序性死亡受体配体1(PD-L1)表达是局部晚期口腔鳞状细胞癌患者预后不良的一个预测指标。
J Immunother Cancer. 2024 Oct 2;12(10):e009617. doi: 10.1136/jitc-2024-009617.
6
Ferroptosis is an effective strategy for cancer therapy.铁死亡是一种有效的癌症治疗策略。
Med Oncol. 2024 Apr 23;41(5):124. doi: 10.1007/s12032-024-02317-5.
7
MicroRNA-561-3p indirectly regulates the PD-L1 expression by targeting ZEB1, HIF1A, and MYC genes in breast cancer.微小RNA-561-3p通过靶向乳腺癌中的ZEB1、HIF1A和MYC基因间接调节程序性死亡受体配体1(PD-L1)的表达。
Sci Rep. 2024 Mar 10;14(1):5845. doi: 10.1038/s41598-024-56511-6.
8
Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer.机器学习分析病理图像预测小细胞肺癌患者免疫治疗 1 年无进展生存率
J Immunother Cancer. 2024 Feb 15;12(2):e007987. doi: 10.1136/jitc-2023-007987.
9
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models.线粒体复合物 III 抑制剂阿托伐醌联合抗 PD-L1 治疗在小鼠癌症模型中的抗肿瘤作用。
Cell Death Dis. 2024 Jan 11;15(1):32. doi: 10.1038/s41419-023-06405-8.
10
Mechanisms of HIF-driven immunosuppression in tumour microenvironment.HIF 驱动的肿瘤微环境免疫抑制机制。
J Egypt Natl Canc Inst. 2023 Aug 30;35(1):27. doi: 10.1186/s43046-023-00186-z.